Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

TADAWUL/4005 stock hub

TADAWUL/4005 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TADAWUL/4005is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2B

Saudi Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TADAWUL/4005

In the news

Latest news · TADAWUL/4005

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 15.3P50 18.4P75 19.8

Trailing P/E16.2

P25 16.2P50 19.4P75 30.1

ROE18.3

P25 9.3P50 15.6P75 21.4

ROIC17.7

P25 7P50 12P75 21

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TADAWUL/4005 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

SAR

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Saudi Arabia
Country code	SA
Enterprise value	SAR 5.2B
Exchange	Saudi Stock Exchange
Financial currency	SAR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	SA139051UIH0
Last refreshed	2026-05-10
Market cap	SAR 5.2B
Price	SAR 116
Price currency	SAR
Sector	Healthcare
Sic	8060
Symbol	tadawul/4005
Website	https://www.care.med.sa

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.16%
EV Earnings	16.18x
EV/EBIT	14.53x
EV/EBITDA	11.11x
EV/FCF	192.23x
EV/Sales	3.22x
FCF yield	0.52%
Forward P/E	15.27x
P/B ratio	2.79x
P/E ratio	16.22x
P/S ratio	3.23x
PE Ratio10 Y	27.61x
PE Ratio3 Y	26.63x
PE Ratio5 Y	25.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.15%
EBITDA Margin	27.35%
FCF margin	1.67%
Gross margin	36.42%
Gross Profit	SAR 582.9M
Gross Profit Growth	30.78%
Gross Profit Growth Q	21.67%
Gross Profit Growth3 Y	26.65%
Gross Profit Growth5 Y	21.39%
Net Income	SAR 318.5M
Net Income Growth	8.07%
Net Income Growth Q	-15.25%
Net Income Growth Years	7%
Net Income Growth3 Y	23.26%
Net Income Growth5 Y	26.77%
Pretax Margin	21.64%
Profit Margin	19.9%
Profitable Years	17
ROA	8.41
Roa5y	7.47
ROCE	14.61
ROE	18.33
Roe5y	16.41
ROIC	17.75
Roic5y	18.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.32%
Cagr1y	-18.23%
Cagr3y	7.64%
Cagr5y	15.3%
Div CAGR10	14.87%
Div CAGR3	44.22%
Div CAGR5	24.57%
EPS Growth	8.25
EPS Growth Q	-15.25
EPS Growth Years	7
EPS Growth3 Y	23.4
EPS Growth5 Y	26.86
FCF Growth	-80.39%
FCF Growth Q	-83.51%
FCF Growth3 Y	-47.56%
FCF Growth5 Y	-22.06%
OCF Growth	-37.07%
OCF Growth Q	-57.88%
OCF Growth10 Y	11.66%
OCF Growth3 Y	-10.79%
OCF Growth5 Y	7.61%
Revenue Growth	23.71x
Revenue Growth Q	8.65x
Revenue Growth Quarters	15x
Revenue Growth Years	6x
Revenue Growth3 Y	20.36x
Revenue Growth5 Y	14.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SAR 0.61
Assets	SAR 2.8B
Cash	SAR 530.6M
Current Assets	SAR 1.5B
Current Liabilities	SAR 344.4M
Debt	SAR 516M
Debt EBITDA	SAR 1.11
Debt Equity	SAR 0.28
Debt FCF	SAR 19.25
Equity	SAR 1.8B
Interest Coverage	13.15
Liabilities	SAR 921.7M
Long Term Assets	SAR 1.3B
Long Term Liabilities	SAR 577.3M
Net Cash	SAR 14.6M
Net Cash By Market Cap	SAR 0.28
Net Cash Growth	-81.54%
Net Debt EBITDA	SAR -0.03
Net Debt Equity	SAR -0.01
Net Debt FCF	SAR -0.54
Tangible Book Value	SAR 1.7B
Tangible Book Value Per Share	SAR 38.1
WACC	5.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.3
Inventory Turnover	16.71
Net Working Capital	SAR 678.2M
Quick ratio	3.93
Working Capital	SAR 1.1B
Working Capital Turnover	SAR 1.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.17%
Dividend Growth	50%
Dividend Growth Years	0%
Dividend per share	SAR 3
Dividend Years	9
Dividend Yield	2.6%
Ex Div Date	2026-05-05
Last Dividend	SAR 3
Payout Frequency	Annual
Payout Ratio	28.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	143.71%
1Y total return	-18.22%
200-day SMA	152.1
3Y total return	24.73%
50-day SMA	126.5
50-day SMA vs 200-day SMA	50under200
5Y total return	103.79%
All Time High	227.6
All Time High Change	-49.21%
All Time High Date	2024-07-17
All Time Low	31.7
All Time Low Change	264.67%
All Time Low Date	2017-11-07
ATR	4
Beta	0.2
Beta1y	0.13
Beta2y	0.16
Ch YTD	-18.99
High	117.1
High52	183.5
High52 Date	2025-10-07
High52ch	-37%
Low	110.1
Low52	109.9
Low52 Date	2026-05-06
Low52ch	5.19%
Ma50ch	-8.65%
Price vs 200-day SMA	-24.01%
RSI	38.1
RSI Monthly	39.54
RSI Weekly	0
Sharpe ratio	-0.49x
Sortino ratio	-0.49
Total Return	2.77%
Tr YTD	-16.78
Tr1m	-13.32%
Tr1w	-0.04%
Tr3m	-24.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SAR 354.5M
Operating Income Growth	41.2
Operating Income Growth Q	91.68
Operating Income Growth3 Y	21.58
Operating Income Growth5 Y	25.45
Operating margin	22.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,620,383%
Net Borrowing	30,139,633
Shares Insiders	0.01%
Shares Institutions	4.25%
Shares Out	44,690,000
Shares Qo Q	0%
Shares Yo Y	-0.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SAR 23.8M
Average Volume	138,101.85x
Bv Per Share	41.38
CAPEX	SAR -127.2M
Ch10y	103.8
Ch1m	-15.62
Ch1w	-2.69
Ch1y	-21.36
Ch3m	-26.37
Ch3y	17.6
Ch5y	86.45
Ch6m	-27.52
Change	5.09%
Change From Open	4.24
Close	110
Days Gap	0.82
Depreciation Amortization	83,213,602
Dollar Volume	61,020,500.4
Earnings Date	2026-07-30
EBIT	SAR 354.5M
EBITDA	SAR 437.8M
EPS	SAR 7.13
F Score	6
FCF	SAR 26.8M
FCF EV Yield	0.52x
FCF Per Share	SAR 0.6
Financing CF	-59,240,367
Fiscal Year End	December
Founded	2,003
Goodwill	133,464,589
Graham Number	81.45323
Graham Upside	-29.54
Income Tax	SAR 27.9M
Investing CF	121,393,113
Is Primary Listing	1
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Lynch Fair Value	SAR 178
Lynch Upside	54.11
Ma150	146.2
Ma150ch	-20.93%
Ma20	122.8
Ma20ch	-5.84%
Net CF	216,124,832
Next Earnings Date	2026-07-30
Open	110.9
P FCF Ratio	192.8
P OCF Ratio	33.55
Payment Date	2026-05-17
Position In Range	78.57
Ppne	1,144,284,108
Price Date	2026-05-07
Price EBITDA	SAR 11.8
Ptbv Ratio	3.03
Relative Volume	3.82x
Revenue	1,600,361,606x
SBC By Revenue	0.19x
Share Based Comp	3,003,396
Tax By Revenue	1.74x
Tax Rate	8.05%
Tr6m	-25.55%
Volume	527,859
Z Score	6.92

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TADAWUL/4005 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.6%

$3.00 annual per share

Payout ratio

+28.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+24.6%

0 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-05-05

Performance

TADAWUL/4005 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TADAWUL/4005?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.3%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

TADAWUL/4005 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.1

Neutral momentum band

Price vs 200-day MA

-24.0%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

-0.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TADAWUL/4005

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tadawul/4005 stock rating?

tadawul/4005 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tadawul/4005 analysis?

The full report lives at /stocks/tadawul/4005/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tadawul/4005?

The latest report frames tadawul/4005 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tadawul/4005 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.